Nanobiotix SA banner

Nanobiotix SA
LSE:0QAV

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
LSE:0QAV
Watchlist
Price: 32.28 EUR -4.89%
Market Cap: €10.2m

Wall St Price Targets

0QAV Price Targets Summary
Nanobiotix SA

Wall Street analysts forecast 0QAV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0QAV is 48.85 EUR with a low forecast of 34.38 EUR and a high forecast of 63.08 EUR.

Lowest Forecast
Price Target
34.38 EUR
7% Upside
Average Forecast
Price Target
48.85 EUR
51% Upside
Highest Forecast
Price Target
63.08 EUR
95% Upside
Nanobiotix SA Competitors:
Price Targets
EOLS
Evolus Inc
142% Upside
4966
Parade Technologies Ltd
13% Upside
NCSM
NCS Multistage Holdings Inc
49% Upside

Revenue
Forecast

13% / Year
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-85%
Average Miss
13% / Year
Past Growth
74% / Year
Estimated Growth
Estimates Accuracy
-85%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 74%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
10%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0QAV's stock price target?
Price Target
48.85 EUR

According to Wall Street analysts, the average 1-year price target for 0QAV is 48.85 EUR with a low forecast of 34.38 EUR and a high forecast of 63.08 EUR.

What is the Revenue forecast for Nanobiotix SA?
Projected CAGR
74%

Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 74%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett